Mitochondrial Involvement in Cisplatin Resistance

Cisplatin is one of the worldwide anticancer drugs and, despite its toxicity and frequent recurrence of resistance phenomena, it still remains the only therapeutic option for several tumors. Circumventing cisplatin resistance remains, therefore, a major goal for clinical therapy and represents a cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Cocetta, Veronica, Ragazzi, Eugenio, Montopoli, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678541/
https://www.ncbi.nlm.nih.gov/pubmed/31295873
http://dx.doi.org/10.3390/ijms20143384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678541/
https://www.ncbi.nlm.nih.gov/pubmed/31295873
http://dx.doi.org/10.3390/ijms20143384

Ejemplares similares